Literature DB >> 20543113

The adaptor molecule Act1 regulates BAFF responsiveness and self-reactive B cell selection during transitional B cell maturation.

Natalia V Giltiay1, Yi Lu, David Allman, Trine N Jørgensen, Xiaoxia Li.   

Abstract

The transitional stage is a key check-point for elimination of autoreactive B cells in the periphery. This selection process requires fine regulation of signals received through BCR and B cell activating factor (BAFF) receptor. We previously identified the adaptor molecule Act1 as a negative regulator of BAFF-mediated signaling. Deficiency of Act1 in mice results in peripheral B cell hyperplasia and development of autoimmunity. In this study, we demonstrate that Act1 plays a critical role in the regulation of transitional B cell survival and maturation. We found that the ratio of late-transitional (T2) to early-transitional (T1) cells was increased in spleens from Act1-deficient mice. Moreover, BAFF stimulation induced better T1 cell survival and promoted more efficient maturation of T1 cells into T2 cells ex vivo in the absence of Act1. BAFF stimulation induced higher levels of the anti-apoptotic Bcl-2 member Mc1-l in Act1-deficient T1 cells than in wild-type control cells, suggesting that Mcl-1 might be one of the key effector molecules for BAFF-mediated survival of the Act1-deficient transitional B cells. Importantly, costimulation with BAFF was able to rescue Act1-deficient T1 cells from BCR-induced apoptosis more effectively than Act1-sufficient T1 B cells. Finally, by using hen egg lysozyme double transgenic mice, we demonstrated that Act1 deficiency can promote the maturation of Ag-specific autoreactive B cells. Taken together, our results suggest that the transitional stage is a critical point of action of Act1 in the elimination of autoreactive B cells and in the regulation of peripheral B cell homeostasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20543113      PMCID: PMC3225255          DOI: 10.4049/jimmunol.0903312

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  B cell development pathways.

Authors:  R R Hardy; K Hayakawa
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

2.  Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators.

Authors:  Benjamin L Hsu; Susan M Harless; R Coleman Lindsley; David M Hilbert; Michael P Cancro
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

3.  Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation.

Authors:  D Allman; R C Lindsley; W DeMuth; K Rudd; S A Shinton; R R Hardy
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

4.  Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome.

Authors:  Joanna Groom; Susan L Kalled; Anne H Cutler; Carl Olson; Stephen A Woodcock; Pascal Schneider; Jurg Tschopp; Teresa G Cachero; Marcel Batten; Julie Wheway; Davide Mauri; Dana Cavill; Tom P Gordon; Charles R Mackay; Fabienne Mackay
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

5.  TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS.

Authors:  J A Gross; S R Dillon; S Mudri; J Johnston; A Littau; R Roque; M Rixon; O Schou; K P Foley; H Haugen; S McMillen; K Waggie; R W Schreckhise; K Shoemaker; T Vu; M Moore; A Grossman; C H Clegg
Journal:  Immunity       Date:  2001-08       Impact factor: 31.745

6.  An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.

Authors:  B Schiemann; J L Gommerman; K Vora; T G Cachero; S Shulga-Morskaya; M Dobles; E Frew; M L Scott
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

7.  BAFF activates Akt and Erk through BAFF-R in an IKK1-dependent manner in primary mouse B cells.

Authors:  Kevin L Otipoby; Yoshiteru Sasaki; Marc Schmidt-Supprian; Alina Patke; Ralph Gareus; Manolis Pasparakis; Alexander Tarakhovsky; Klaus Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-19       Impact factor: 11.205

8.  Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

Authors:  F Mackay; S A Woodcock; P Lawton; C Ambrose; M Baetscher; P Schneider; J Tschopp; J L Browning
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

9.  BAFF mediates survival of peripheral immature B lymphocytes.

Authors:  M Batten; J Groom; T G Cachero; F Qian; P Schneider; J Tschopp; J L Browning; F Mackay
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

10.  Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen.

Authors:  P Schneider; H Takatsuka; A Wilson; F Mackay; A Tardivel; S Lens; T G Cachero; D Finke; F Beermann; J Tschopp
Journal:  J Exp Med       Date:  2001-12-03       Impact factor: 14.307

View more
  13 in total

Review 1.  Function of Act1 in IL-17 family signaling and autoimmunity.

Authors:  Ling Wu; Jarod Zepp; Xiaoxia Li
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 2.  Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.

Authors:  Robert C Rickert; Julia Jellusova; Ana V Miletic
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

3.  The differential regulation of human ACT1 isoforms by Hsp90 in IL-17 signaling.

Authors:  Ling Wu; Chenhui Wang; Bertrand Boisson; Saurav Misra; Patricia Rayman; James H Finke; Anne Puel; Jean-Laurent Casanova; Xiaoxia Li
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

4.  TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development.

Authors:  Carlo Perricone; Cinzia Ciccacci; Fulvia Ceccarelli; Davide Di Fusco; Francesca Romana Spinelli; Enrica Cipriano; Giuseppe Novelli; Guido Valesini; Fabrizio Conti; Paola Borgiani
Journal:  Immunogenetics       Date:  2013-07-09       Impact factor: 2.846

5.  Spontaneous loss of tolerance of autoreactive B cells in Act1-deficient rheumatoid factor transgenic mice.

Authors:  Natalia V Giltiay; Yi Lu; Jaime L Cullen; Trine N Jørgensen; Mark J Shlomchik; Xiaoxia Li
Journal:  J Immunol       Date:  2013-07-31       Impact factor: 5.422

6.  Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.

Authors:  Julia Jellusova; Ana V Miletic; Matthew H Cato; Wai-Wai Lin; Yinling Hu; Gail A Bishop; Mark J Shlomchik; Robert C Rickert
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

Review 7.  Antigen and cytokine receptor signals guide the development of the naïve mature B cell repertoire.

Authors:  Sarah L Rowland; Kathryn Tuttle; Raul M Torres; Roberta Pelanda
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

8.  Lack of T cells in Act1-deficient mice results in elevated IgM-specific autoantibodies but reduced lupus-like disease.

Authors:  Angela C Johnson; Laura M Davison; Natalia V Giltiay; Chairut Vareechon; Xiaoxia Li; Trine N Jørgensen
Journal:  Eur J Immunol       Date:  2012-07       Impact factor: 5.532

9.  Intrinsic autoimmune capacities of hematopoietic cells from female New Zealand hybrid mice.

Authors:  A David; A Trigunaite; M K Macleod; A C Johnson; P Marrack; T N Jørgensen
Journal:  Genes Immun       Date:  2014-01-30       Impact factor: 2.676

10.  Differential Roles of IDO1 and IDO2 in T and B Cell Inflammatory Immune Responses.

Authors:  Lauren M F Merlo; James B DuHadaway; James D Montgomery; Wei-Dan Peng; Peter J Murray; George C Prendergast; Andrew J Caton; Alexander J Muller; Laura Mandik-Nayak
Journal:  Front Immunol       Date:  2020-08-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.